Free Trial
NASDAQ:MIRA

MIRA Pharmaceuticals (MIRA) Stock Price, News & Analysis

MIRA Pharmaceuticals logo
$1.25 -0.02 (-1.57%)
Closing price 04:00 PM Eastern
Extended Trading
$1.26 +0.01 (+0.80%)
As of 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MIRA Pharmaceuticals Stock (NASDAQ:MIRA)

Advanced

Key Stats

Today's Range
$1.24
$1.29
50-Day Range
$1.25
$2.02
52-Week Range
$0.73
$2.56
Volume
389,864 shs
Average Volume
817,342 shs
Market Capitalization
$23.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Strong Buy

Company Overview

MIRA Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

MIRA MarketRank™: 

MIRA Pharmaceuticals scored higher than 56% of companies evaluated by MarketBeat, and ranked 466th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MIRA Pharmaceuticals has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    MIRA Pharmaceuticals has a consensus price target of $17.00, representing about 1,260.0% upside from its current price of $1.25.

  • Amount of Analyst Coverage

    MIRA Pharmaceuticals has received no research coverage in the past 90 days.

  • Read more about MIRA Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for MIRA Pharmaceuticals are expected to grow in the coming year, from ($0.60) to ($0.54) per share.

  • Price to Book Value per Share Ratio

    MIRA Pharmaceuticals has a P/B Ratio of 9.62. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MIRA Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    1.48% of the float of MIRA Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    MIRA Pharmaceuticals has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MIRA Pharmaceuticals has recently decreased by 20.17%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MIRA Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    MIRA Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.48% of the float of MIRA Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    MIRA Pharmaceuticals has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MIRA Pharmaceuticals has recently decreased by 20.17%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    MIRA Pharmaceuticals has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for MIRA Pharmaceuticals this week, compared to 1 article on an average week.
  • Search Interest

    17 people have searched for MIRA on MarketBeat in the last 30 days. This is an increase of 467% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added MIRA Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MIRA Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.65% of the stock of MIRA Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 35.16% of the stock of MIRA Pharmaceuticals is held by institutions.

  • Read more about MIRA Pharmaceuticals' insider trading history.
Receive MIRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MIRA Stock News Headlines

Mira Pharmaceuticals reports Ketamir-2 data in PTSD
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
See More Headlines

MIRA Stock Analysis - Frequently Asked Questions

MIRA Pharmaceuticals' stock was trading at $1.14 at the beginning of 2025. Since then, MIRA shares have increased by 9.6% and is now trading at $1.25.

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) issued its quarterly earnings results on Thursday, August, 14th. The company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.02.

MIRA Pharmaceuticals (MIRA) raised $9 million in an initial public offering on Thursday, August 3rd 2023. The company issued 1,275,000 shares at $7.00 per share.

MIRA Pharmaceuticals' top institutional investors include International Assets Investment Management LLC (0.21%), Creative Planning (0.13%) and XTX Topco Ltd (0.13%). Insiders that own company stock include George Cappy, Erez Aminov and Brian Patrick Mcnulty.
View institutional ownership trends
.

Shares of MIRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MIRA Pharmaceuticals investors own include Plug Power (PLUG), Workhorse Group (WKHS), FuelCell Energy (FCEL), Fortress Biotech (FBIO), Ovid Therapeutics (OVID), Alamos Gold (AGI) and GeoVax Labs (GOVX).

Company Calendar

Last Earnings
8/14/2025
Today
9/19/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MIRA
Previous Symbol
NASDAQ:MIRA
CIK
1904286
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$17.00
Potential Upside/Downside
+1,254.6%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.49)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.85 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-406.70%
Return on Assets
-328.44%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.80
Quick Ratio
2.80

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
9.65

Miscellaneous

Outstanding Shares
19,069,000
Free Float
17,801,000
Market Cap
$23.93 million
Optionable
Not Optionable
Beta
1.75

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:MIRA) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners